Top Markets
Coin of the day
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Rangering i aksjer #41534
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Aksjekurs
$0.00156481
Sist synkronisert: 2024-06-05
Markedsverdi
$17.03K
Endring (1 dag)
2.11%
Endring (1 år)
0.00%
Land
GB
Handel Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Kategori

EPS for Oxford Cannabinoid Technologies Holdings Plc (OCTP)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Oxford Cannabinoid Technologies Holdings Plc er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Oxford Cannabinoid Technologies Holdings Plc fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter